Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design

Journal of Immunology

Volumn 187, Issue 8, 2011, Pages 4268-4279

  Weiskopf, Daniela ^a   Yauch, Lauren E ^a   Angelo, Michael A ^a   John, Daisy V ^a   Greenbaum, Jason A ^a   Sidney, John ^a   Kolla, Ravi V ^a   De Silva, Aruna D ^b   De Silva, Aravinda M ^c   Grey, Howard ^a   Peters, Bjoern ^a   Shresta, Sujan ^a   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b Genetech Research Institute   (Sri Lanka)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; EPITOPE; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5;

ADULT; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DRUG DESIGN; EPITOPE MAPPING; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; T LYMPHOCYTE; TRANSGENE; VIRUS REPLICATION;

ANIMALS; DENGUE VACCINES; DISEASE MODELS, ANIMAL; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 80054719513     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101970     Document Type: Article

References (84)

1. Kyle, J. L., and E. Harris. 2008. Global spread and persistence of dengue. Annu. Rev. Microbiol. 62: 71-92.
2. WHO. 2009. Dengue: Guidelines for Diagnosis. Treatment, Prevention and Control, Geneva, Switzerland.
3. Burke, D., and T. Monath. 2001. Flaviviruses. In Field's Virology. P. H. D. Knipe, ed. William and Wilkins, Philadelphia, p. 1043-1126.
4. Rothman, A. L. 2010. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr. Top. Microbiol. Immunol. 338: 83-98.
5. Mathew, A., and A. L. Rothman. 2008. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 225: 300-313.
6. Nielsen, D. G. 2009. The relationship of interacting immunological components in dengue pathogenesis. Virol. J. 6: 211.
7. Fink, J., F. Gu, and S. G. Vasudevan. 2006. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev. Med. Virol. 16: 263-275. (Pubitemid 44140722)
8. Yauch, L. E., T. R. Prestwood, M. M. May, M. M. Morar, R. M. Zellweger, B. Peters, A. Sette, and S. Shresta. 2010. CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J. Immunol. 185: 5405-5416.
9. Yauch, L. E., R. M. Zellweger, M. F. Kotturi, A. Qutubuddin, J. Sidney, B. Peters, T. R. Prestwood, A. Sette, and S. Shresta. 2009. A protective role for dengue virus-specific CD8+ T cells. J. Immunol. 182: 4865-4873.
10. Livingston, P. G., I. Kurane, L. C. Dai, Y. Okamoto, C. J. Lai, R. Men, S. Karaki, M. Takiguchi, and F. A. Ennis. 1995. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J. Immunol. 154: 1287-1295.
11. Kurane, I., A. Meager, and F. A. Ennis. 1989. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J. Exp. Med. 170: 763-775. (Pubitemid 19226663)
12. Gagnon, S. J., F. A. Ennis, and A. L. Rothman. 1999. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J. Virol. 73: 3623-3629. (Pubitemid 29189803)
13. Mathew, A., I. Kurane, A. L. Rothman, L. L. Zeng, M. A. Brinton, and F. A. Ennis. 1996. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J. Clin. Invest. 98: 1684-1691. (Pubitemid 26327880)
14. Gunther, V. J., R. Putnak, K. H. Eckels, M. P. Mammen, J. M. Scherer, A. Lyons, M. B. Sztein, and W. Sun. 2011. A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine 29: 3895-3904.
15. Burke, D. S., A. Nisalak, D. E. Johnson, and R. M. Scott. 1988. A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38: 172-180.
16. Sangkawibha, N., S. Rojanasuphot, S. Ahandrik, S. Viriyapongse, S. Jatanasen, V. Salitul, B. Phanthumachinda, and S. B. Halstead. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120: 653-669. (Pubitemid 15210730)
17. Morens, D. M. 1994. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin. Infect. Dis. 19: 500-512. (Pubitemid 24286955)
18. Halstead, S. B., S. Mahalingam, M. A. Marovich, S. Ubol, and D. M. Mosser. 2010. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect. Dis. 10: 712-722.
19. Mongkolsapaya, J., W. Dejnirattisai, X. N. Xu, S. Vasanawathana, N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9: 921-927. (Pubitemid 36889936)
20. Halstead, S. B., S. Rojanasuphot, and N. Sangkawibha. 1983. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg. 32: 154-156. (Pubitemid 13186851)
21. Fu, J., B. H. Tan, E. H. Yap, Y. C. Chan, and Y. H. Tan. 1992. Full-length cDNA sequence of dengue type 1 virus (Singapore strain S275/90). Virology 188: 953-958.
22. Veiga-Fernandes, H., U. Walter, C. Bourgeois, A. McLean, and B. Rocha. 2000. Response of naïve and memory CD8+ T cells to antigen stimulation in vivo. Nat. Immunol. 1: 47-53.
23. Kotturi, M. F., J. Botten, M. Maybeno, J. Sidney, J. Glenn, H. H. Bui, C. Oseroff, S. Crotty, B. Peters, H. Grey, et al. 2010. Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage. Immunome Res. 6: 4.
24. Kotturi, M. F., E. Assarsson, B. Peters, H. Grey, C. Oseroff, V. Pasquetto, and A. Sette. 2009. Of mice and humans: how good are HLA transgenic mice as a model of human immune responses? Immunome Res. 5: 3.
25. Pasquetto, V., H. H. Bui, R. Giannino, C. Banh, F. Mirza, J. Sidney, C. Oseroff, D. C. Tscharke, K. Irvine, J. R. Bennink, et al. 2005. HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. [Published erratum appears in 2005. J. Immunol. 175: 8440.] J. Immunol. 175: 5504-5515. (Pubitemid 41456438)
26. Shresta, S., J. L. Kyle, H. M. Snider, M. Basavapatna, P. R. Beatty, and E. Harris. 2004. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J. Virol. 78: 2701-2710. (Pubitemid 38314329)
27. Lin, Y. L., C. L. Liao, L. K. Chen, C. T. Yeh, C. I. Liu, S. H. Ma, Y. Y. Huang, Y. L. Huang, C. L. Kao, and C. C. King. 1998. Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 72: 9729-9737.
28. Perry, S. T., T. R. Prestwood, S. M. Lada, C. A. Benedict, and S. Shresta. 2009. Cardif-mediated signaling controls the initial innate response to dengue virus in vivo. J. Virol. 83: 8276-8281.
29. Prestwood, T. R., D. M. Prigozhin, K. L. Sharar, R. M. Zellweger, and S. Shresta. 2008. A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads. J. Virol. 82: 8411-8421.
30. Diamond, M. S., D. Edgil, T. G. Roberts, B. Lu, and E. Harris. 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74: 7814-7823. (Pubitemid 30641625)
31. Alexander, J., C. Oseroff, J. Sidney, P. Wentworth, E. Keogh, G. Hermanson, F. V. Chisari, R. T. Kubo, H. M. Grey, and A. Sette. 1997. Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. J. Immunol. 159: 4753-4761. (Pubitemid 127471010)
32. Alexander, J., C. Oseroff, J. Sidney, and A. Sette. 2003. Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes. Hum. Immunol. 64: 211-223. (Pubitemid 36197349)
33. Zhang, Q., P. Wang, Y. Kim, P. Haste-Andersen, J. Beaver, P. E. Bourne, H. H. Bui, S. Buus, S. Frankild, J. Greenbaum, et al. 2008. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 36(Web Server issue): W513-W518.
34. Wang, P., J. Sidney, C. Dow, B. Mothé, A. Sette, and B. Peters. 2008. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLOS Comput. Biol. 4: e1000048.
35. Sidney, J., E. Assarsson, C. Moore, S. Ngo, C. Pinilla, A. Sette, and B. Peters. 2008. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 4: 2.
36. Sidney, J., S. Southwood, C. Oseroff, M. F. del Guercio, A. Sette, and H. M. Grey. 2001. Measurement of MHC/peptide interactions by gel filtration. Curr. Protoc. Immunol. Chapter 18: Unit 18.13.
37. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 142: 3320-3328. (Pubitemid 19129961)
38. Kanakaratne, N., W. M. Wahala, W. B. Messer, H. A. Tissera, A. Shahani, N. Abeysinghe, A. M. de-Silva, and M. Gunasekera. 2009. Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg. Infect. Dis. 15: 192-199.
39. Kraus, A. A., W. Messer, L. B. Haymore, and A. M. de Silva. 2007. Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 45: 3777-3780. (Pubitemid 350156883)
40. Moutaftsi, M., B. Peters, V. Pasquetto, D. C. Tscharke, J. Sidney, H. H. Bui, H. Grey, and A. Sette. 2006. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat. Biotechnol. 24: 817-819. (Pubitemid 44086622)
41. Roehrig, J. T., A. J. Johnson, A. R. Hunt, B. J. Beaty, and J. H. Mathews. 1992. Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J. Virol. 66: 3385-3390.
42. Greenbaum, J., J. Sidney, J. Chung, C. Brander, B. Peters, and A. Sette. 2011. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 63: 325-335.
43. Vita, R., L. Zarebski, J. A. Greenbaum, H. Emami, I. Hoof, N. Salimi, R. Damle, A. Sette, and B. Peters. 2010. The immune epitope database 2.0. Nucleic Acids Res. 38(Database issue): D854-D862.
44. Yauch, L. E., and S. Shresta. 2008. Mouse models of dengue virus infection and disease. Antiviral Res. 80: 87-93.
45. Gianfrani, C., C. Oseroff, J. Sidney, R. W. Chesnut, and A. Sette. 2000. Human memory CTL response specific for influenza A virus is broad and multispecific. Hum. Immunol. 61: 438-452. (Pubitemid 30238274)
46. Wentworth, P. A., A. Vitiello, J. Sidney, E. Keogh, R. W. Chesnut, H. Grey, and A. Sette. 1996. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. Eur. J. Immunol. 26: 97-101. (Pubitemid 26028418)
47. Shirai, M., T. Arichi, M. Nishioka, T. Nomura, K. Ikeda, K. Kawanishi, V. H. Engelhard, S. M. Feinstone, and J. A. Berzofsky. 1995. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J. Immunol. 154: 2733-2742.
48. Ressing, M. E., A. Sette, R. M. Brandt, J. Ruppert, P. A. Wentworth, M. Hartman, C. Oseroff, H. M. Grey, C. J. Melief, and W. M. Kast. 1995. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J. Immunol. 154: 5934-5943.
49. Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, and R. W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173: 1007-1015.
50. Diamond, D. J., J. York, J. Y. Sun, C. L. Wright, and S. J. Forman. 1997. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90: 1751-1767. (Pubitemid 27377285)
51. Firat, H., F. Garcia-Pons, S. Tourdot, S. Pascolo, A. Scardino, Z. Garcia, M. L. Michel, R. W. Jack, G. Jung, K. Kosmatopoulos, et al. 1999. H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur. J. Immunol. 29: 3112-3121. (Pubitemid 29484201)
52. Le, A. X., E. J. Bernhard, M. J. Holterman, S. Strub, P. Parham, E. Lacy, and V. H. Engelhard. 1989. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J. Immunol. 142: 1366-1371. (Pubitemid 19067513)
53. Man, S., M. H. Newberg, V. L. Crotzer, C. J. Luckey, N. S. Williams, Y. Chen, E. L. Huczko, J. P. Ridge, and V. H. Engelhard. 1995. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice. Int. Immunol. 7: 597-605.
54. Rothman, A. L. 2003. Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 60: 397-419. (Pubitemid 137639380)
55. Duangchinda, T., W. Dejnirattisai, S. Vasanawathana, W. Limpitikul, N. Tangthawornchaikul, P. Malasit, J. Mongkolsapaya, and G. Screaton. 2010. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc. Natl. Acad. Sci. USA 107: 16922-16927.
56. Rothman, A. L. 2004. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 113: 946-951. (Pubitemid 38544112)
57. Twiddy, S. S., J. J. Farrar, N. Vinh Chau, B. Wills, E. A. Gould, T. Gritsun, G. Lloyd, and E. C. Holmes. 2002. Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. Virology 298: 63-72. (Pubitemid 34734880)
58. Holmes, E. C., and S. S. Burch. 2000. The causes and consequences of genetic variation in dengue virus. Trends Microbiol. 8: 74-77. (Pubitemid 30100330)
59. Yachi, P. P., J. Ampudia, T. Zal, and N. R. Gascoigne. 2006. Altered peptide ligands induce delayed CD8-T cell receptor interaction - a role for CD8 in distinguishing antigen quality. Immunity 25: 203-211. (Pubitemid 44224141)
60. Kast, W. M., R. M. Brandt, J. Sidney, J. W. Drijfhout, R. T. Kubo, H. M. Grey, C. J. Melief, and A. Sette. 1994. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152: 3904-3912. (Pubitemid 24111062)
61. Valdar, W. S. 2002. Scoring residue conservation. Proteins 48: 227-241. (Pubitemid 34743413)
62. Khan, A. M., O. Miotto, A. T. Heiny, J. Salmon, K. N. Srinivasan, E. J. Nascimento, E. T. Marques, Jr., V. Brusic, T. W. Tan, and J. T. August. 2006. A systematic bioinformatics approach for selection of epitope-based vaccine targets. Cell. Immunol. 244: 141-147. (Pubitemid 46733910)
63. Klein, J. 1986. Natural History of the Major Histocompatibility Complex. Wiley, New York.
64. Hughes, A. L., and M. Nei. 1992. Maintenance of MHC polymorphism. Nature 355: 402-403.
65. Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50: 201-212. (Pubitemid 30099525)
66. Doolan, D. L., S. Southwood, R. Chesnut, E. Appella, E. Gomez, A. Richards, Y. I. Higashimoto, A. Maewal, J. Sidney, R. A. Gramzinski, et al. 2000. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 165: 1123-1137. (Pubitemid 30484785)
67. Wilson, C. C., B. Palmer, S. Southwood, J. Sidney, Y. Higashimoto, E. Appella, R. Chesnut, A. Sette, and B. D. Livingston. 2001. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. J. Virol. 75: 4195-4207. (Pubitemid 32410132)
68. Southwood, S., J. Sidney, A. Kondo, M. F. del Guercio, E. Appella, S. Hoffman, R. T. Kubo, R. W. Chesnut, H. M. Grey, and A. Sette. 1998. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160: 3363-3373. (Pubitemid 28164729)
69. Momburg, F., J. Roelse, J. C. Howard, G. W. Butcher, G. J. Hämmerling, and J. J. Neefjes. 1994. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367: 648-651. (Pubitemid 24067707)
70. Heemels, M. T., and H. L. Ploegh. 1994. Substrate specificity of allelic variants of the TAP peptide transporter. Immunity 1: 775-784.
71. Kubo, R. T., A. Sette, H. M. Grey, E. Appella, K. Sakaguchi, N. Z. Zhu, D. Arnott, N. Sherman, J. Shabanowitz, H. Michel, et al. 1994. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152: 3913-3924. (Pubitemid 24111063)
72. Kiepiela, P., A. J. Leslie, I. Honeyborne, D. Ramduth, C. Thobakgale, S. Chetty, P. Rathnavalu, C. Moore, K. J. Pfafferott, L. Hilton, et al. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-775.
73. Bihl, F., N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, et al. 2006. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 176: 4094-4101. (Pubitemid 44264388)
74. Boon, A. C., G. De Mutsert, R. A. Fouchier, K. Sintnicolaas, A. D. Osterhaus, and G. F. Rimmelzwaan. 2004. Preferential HLA usage in the influenza virus-specific CTL response. J. Immunol. 172: 4435-4443. (Pubitemid 38375259)
75. Lacey, S. F., M. C. Villacres, C. La Rosa, Z. Wang, J. Longmate, J. Martinez, J. C. Brewer, S. Mekhoubad, R. Maas, J. M. Leedom, et al. 2003. Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles. Hum. Immunol. 64: 440-452. (Pubitemid 36373774)
76. Lewinsohn, D. A., E. Winata, G. M. Swarbrick, K. E. Tanner, M. S. Cook, M. D. Null, M. E. Cansler, A. Sette, J. Sidney, and D. M. Lewinsohn. 2007. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog. 3: 1240-1249. (Pubitemid 47510277)
77. Axelsson-Robertson, R., F. Weichold, D. Sizemore, M. Wulf, Y. A. Skeiky, J. Sadoff, and M. J. Maeurer. 2010. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses. Immunology 129: 496-505.
78. Zivna, I., S. Green, D. W. Vaughn, S. Kalayanarooj, H. A. Stephens, D. Chandanayingyong, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J. Immunol. 168: 5959-5965. (Pubitemid 34556187)
79. Stephens, H. A., R. Klaythong, M. Sirikong, D. W. Vaughn, S. Green, S. Kalayanarooj, T. P. Endy, D. H. Libraty, A. Nisalak, B. L. Innis, et al. 2002. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60: 309-318. (Pubitemid 36020803)
80. Appanna, R., S. Ponnampalavanar, L. Lum Chai See, and S. D. Sekaran. 2010. Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population. PLoS ONE 5: e13029.
81. Simmons, C. P., T. Dong, N. V. Chau, N. T. Dung, T. N. Chau, T. T. Thao, N. T. Dung, T. T. Hien, S. Rowland-Jones, and J. Farrar. 2005. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J. Virol. 79: 5665-5675. (Pubitemid 40548235)
82. Appanna, R., T. L. Huat, L. L. See, P. L. Tan, J. Vadivelu, and S. Devi. 2007. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clin. Vaccine Immunol. 14: 969-977.
83. Mongkolsapaya, J., T. Duangchinda, W. Dejnirattisai, S. Vasanawathana, P. Avirutnan, A. Jairungsri, N. Khemnu, N. Tangthawornchaikul, P. Chotiyarnwong, K. Sae-Jang, et al. 2006. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J. Immunol. 176: 3821-3829. (Pubitemid 43364031)
84. Wen, J. S., L. F. Jiang, J. M. Zhou, H. J. Yan, and D. Y. Fang. 2008. Computational prediction and identification of dengue virus-specific CD4(+) T-cell epitopes. Virus Res. 132: 42-48.